Help on YouTube for Type 2’s Considering Insulin

Sanofi-aventis U.S., a maker of insulin as well as many other pharmaceuticals, announced last month the launch of their new YouTube diabetes channel that’s designed to challenge the barriers, myths, and misperceptions about insulin use and empower people living with type 2 diabetes to make better-informed decisions for managing their condition.  The channel is part of their broader GoInsulin campaign, a multi-media resource for people living with type 2 diabetes to help dispel the myths about insulin.

Many patients feel that starting insulin means that they have failed. It doesn’t help that some healthcare providers use insulin as a warning, “If you don’t manage your diet, exercise, and weight, you’ll end up on insulin.” GoInsulin was developed to help correct myths about diabetes and insulin and to help educate patients so they can make the best decision about their treatment.

The GoInsulin Channel features real-life inspiring video stories of people with type 2 diabetes who use insulin as part of their overall diabetes treatment plan, while also balancing information about the risks and benefits of insulin.

Visitors to an adjunct website can play an interactive insulin “Myth or Reality” game, view digital video clips featuring real patients’ insulin success stories and download a customizable insulin discussion guide to help them get the most out of their next visit to a healthcare professional. Additionally, visitors to the site are invited to share their experiences with insulin and.

“There are a lot of myths and misperceptions out there about insulin.  Many people with type 2 diabetes who are not able to achieve blood glucose control with diet, exercise and other diabetes medications alone, see the need for insulin as a sign of failure,” said Lynn Crowe, Senior Manager, Metabolism Marketing, sanofi-aventis U.S, in a press release.  “For some, adding insulin to their treatment plan may be an appropriate option for helping them get their blood sugar in control.

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.